Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.120
-0.001 (-0.66%)
Feb 21, 2025, 4:00 PM EST - Market closed
Zomedica Employees
Zomedica had 144 employees as of December 31, 2023. The number of employees increased by 59 or 69.41% compared to the previous year.
Employees
144
Change (1Y)
59
Growth (1Y)
69.41%
Revenue / Employee
$185,604
Profits / Employee
-$431,903
Market Cap
117.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ZOM News
- 10 days ago - Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - Accesswire
- 16 days ago - Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - Accesswire
- 6 weeks ago - Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - Accesswire
- 2 months ago - Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - Accesswire
- 2 months ago - Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - Accesswire
- 3 months ago - Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - Accesswire
- 3 months ago - Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - Accesswire
- 3 months ago - Noble Capital Markets Initiates Equity Research Coverage on Zomedica - Accesswire